Literature DB >> 15520091

Integrating adherence to highly active antiretroviral therapy into children's daily lives: a qualitative study.

Naïma Hammami1, Christiana Nöstlinger, Tom Hoerée, Pierre Lefèvre, Tyl Jonckheer, Patrick Kolsteren.   

Abstract

OBJECTIVE: To acquire a deeper understanding of factors that influence adherence to highly active antiretroviral therapy (HAART) in a pediatric population.
METHODS: We performed a qualitative study of adherence in children who receive HAART in a Belgian pediatric acquired immune deficiency syndrome referral center. Eleven primary caregivers were interviewed to assess their child's adherence and influencing factors. The interview guidelines were developed on the basis of an extensive literature review. Adherence to treatment was assessed using caregivers' self-report and laboratory results. Content analysis for common items was performed, and statements of adherent and less-adherent patients were compared.
RESULTS: Three main factors influenced adherence. Adherent patients were found to internalize the medical information to a stronger extent than less-adherent patients. Adherent patients showed stronger motivation to stick to the medical regimen on the basis of personal cost-benefit analyses, ie, perceived benefits outweighed the costs or difficulties experienced. Adherent patients developed greater problem-solving capacities, ie, ways to deal with practical complications of medication intake. The interviews revealed a fourth, more dynamic component: knowledge, motivation, and capacities evolved in a progressive way, related to individual stages of coping with human immunodeficiency virus (HIV).
CONCLUSIONS: The data suggest that coping with HIV and the process of establishing good adherence may be interrelated. Caregivers who accept the disease may be more likely to internalize the received information and thus develop a stronger motivation to fight for the child's life. Problem-solving skills sustain this adherence, and medication becomes a priority in the adherent caregivers' daily lives. On the contrary, less-adherent caregivers may be situated at less advanced stages of the coping process. Thus, tailor-made approaches adapted to the individual HIV-related coping strategies need to be developed to improve adherence in children and caregivers.

Entities:  

Mesh:

Year:  2004        PMID: 15520091     DOI: 10.1542/peds.2004-0085

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

Review 1.  How qualitative methods contribute to understanding combination antiretroviral therapy adherence.

Authors:  Andrea Sankar; Carol Golin; Jane M Simoni; Mark Luborsky; Cynthia Pearson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

2.  Disclosure of their HIV status to perinatally infected youth using the adapted Blasini disclosure model in Haiti and the Dominican Republic: preliminary results.

Authors:  Consuelo M Beck-Sagué; Jessy Dévieux; Maria Claudia Pinzón-Iregui; Leonel Lerebours-Nadal; Rosa Abreu-Pérez; Rachel Bertrand; Vanessa Rouzier; Stephanie Gaston; Gladys Ibanez; Mina Halpern; Jean W Pape; Patricia Dorceus; Sharice M Preston; Andrew G Dean; Stephen W Nicholas; Ileana Blasini
Journal:  AIDS       Date:  2015-06       Impact factor: 4.177

3.  Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV.

Authors:  Patricia A Garvie; Sean S Brummel; Susannah M Allison; Kathleen M Malee; Claude A Mellins; Megan L Wilkins; Lynnette L Harris; E Doyle Patton; Miriam C Chernoff; Richard M Rutstein; Mary E Paul; Sharon L Nichols
Journal:  Pediatr Infect Dis J       Date:  2017-08       Impact factor: 2.129

4.  Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

Authors:  Natella Y Rakhmanina; John N van den Anker; Steven J Soldin; Ron H van Schaik; Nick Mordwinkin; Michael N Neely
Journal:  Ther Drug Monit       Date:  2010-06       Impact factor: 3.681

5.  We never thought this would happen: transitioning care of adolescents with perinatally acquired HIV infection from pediatrics to internal medicine.

Authors:  Tara Vijayan; Andrea L Benin; Krystn Wagner; Sostena Romano; Warren A Andiman
Journal:  AIDS Care       Date:  2009-10

6.  Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: insights from a qualitative study.

Authors:  Bradley C Fetzer; Bavon Mupenda; Jean Lusiama; Faustin Kitetele; Carol Golin; Frieda Behets
Journal:  AIDS Patient Care STDS       Date:  2011-08-08       Impact factor: 5.078

7.  Prevalence, perceptions, and correlates of pediatric HIV disclosure in an HIV treatment program in Kenya.

Authors:  Grace C John-Stewart; Grace Wariua; Kristin M Beima-Sofie; Barbra A Richardson; Carey Farquhar; Elizabeth Maleche-Obimbo; Dorothy Mbori-Ngacha; Dalton Wamalwa
Journal:  AIDS Care       Date:  2012-12-20

Review 8.  Disclosure of their HIV status to infected children: a review of the literature.

Authors:  María C Pinzón-Iregui; Consuelo M Beck-Sagué; Robert M Malow
Journal:  J Trop Pediatr       Date:  2012-10-15       Impact factor: 1.165

9.  Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications.

Authors:  Stephanie L Marhefka; Linda J Koenig; Susannah Allison; Pamela Bachanas; Marc Bulterys; Linda Bettica; Vicki J Tepper; Elaine J Abrams
Journal:  AIDS Patient Care STDS       Date:  2008-08       Impact factor: 5.078

Review 10.  Pediatric adherence to HIV antiretroviral therapy.

Authors:  Jessica Haberer; Claude Mellins
Journal:  Curr HIV/AIDS Rep       Date:  2009-11       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.